Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)

NCT00883129 is registered in ClinicalTrials.gov with Michael Roth as lead sponsor.

NCT NCT00883129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Lead sponsor
Michael Roth
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
November 30, 2015
Enrollment
142 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, scleroderma